Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Merger talks are over for Care New England, Lifespan

Merger talks between Care New England, one of the largest healthcare systems in Rhode Island, Brown University and Lifespan, operator of Rhode Island Hospital, are over.

Thumbnail

HHS will not push rebate rule forward

A proposed rule to eliminate drug rebates will not be pushed through. However, President Trump could still take on the pharmaceutical industry in other ways.

Thumbnail

CVS expands HealthHub concept to new markets

After introducing its new HealthHub concept store in Texas, CVS Health is spreading the store model to Boston, Dallas/Fort Worth, Maryland, North Carolina, Ohio and Virginia, the company announced.

Thumbnail

5 new payment models proposed for kidney care

HHS and CMS are following through on an executive order from President Trump to overhaul kidney care in the nation by proposing five new payment models.

Thumbnail

ACOs are slow to adopt downside risk

Only 28% of ACOs formed in 2012 have taken on downside risk, while just 33% had at least one contract with downside risk in 2018, according to a study published in Health Affairs.

Thumbnail

Trump preparing another exec order on drug prices

President Trump is preparing to issue an executive order that would declare a favored nations clause for drug prices, ensuring the U.S. would not pay higher prices than other countries for prescription medications, CNBC reported.

Thumbnail

Obamacare lawsuit heads to appeals court

The biggest challenge to the Affordable Care Act to date heads to the 5th U.S. Circuit Court of Appeals in New Orleans Tuesday, July 9, for scheduled oral arguments in the case.

Thumbnail

Trump rule to disclose drug prices blocked by judge

A federal judge has blocked the Trump administration’s rule requiring drugmakers to publish the list prices of prescription medications in direct-to-consumer television advertisements.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”